Theratome Bio, Inc. — Form D
Theratome Bio, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-21. The offering totals $950K, of which $29K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-21
- Form: D
- Accession: 0001671248-23-000005
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $950K
- Amount sold: $29K
- Remaining: $922K
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2023-09-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-492638
Issuer
- Name: Theratome Bio, Inc.
- CIK: 0001671248
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 9128 Lakes at 610 Drive, Houston, TX, 77054
- Phone: 8324525117
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Keith T March MD PhD | Director | Houston, TX |
| Brad T Miller | Director | Houston, TX |
| Michael T Redman | Director | Houston, TX |
| Michael Donald Trotta | Director | Houston, TX |
| Keith T March MD PhD | Executive Officer | Houston, TX |
| James Donald Payne | Executive Officer | Houston, TX |
| Michael T Redman | Executive Officer | Houston, TX |
| Jennifer Rhodes | Executive Officer | Noblesville, IN |
| Brad L Miller | Director | Fishers, IN |
| Scott A Jones | Director | Fishers, IN |
| Wade Lange | Executive Officer | West Lafayette, IN |
| Keith L March | Director | Fishers, IN |
Other filings by this issuer (1)
More